HealthFDA approves Johnson & Johnson’s Spravato for standalone depression treatmentkuwait-live.comJanuary 21, 2025January 21, 2025 January 21, 2025January 21, 2025 The U.S. Food and Drug Administration (FDA) has approved Johnson & Johnson’s nasal spray, Spravato, as a standalone treatment for adults with major depressive disorder...
